1. Induced pluripotent stem cell-based therapies for organ fibrosis
    Wei Cheng et al, 2023, Frontiers in Bioengineering and Biotechnology CrossRef
  2. The iPSC secretome is beneficial for in vitro propagation of primary osteoarthritic chondrocytes cell lines
    Monika A. Rosochowicz et al, 2024, Biochemical and Biophysical Research Communications CrossRef
  3. Naringenin attenuates fibroblast activation and inflammatory response in a mechanical stretch-induced hypertrophic scar mouse model
    Shengzhou Shan et al, 2017, Molecular Medicine Reports CrossRef
  4. Stem Cells in Wound Healing and Scarring
    Roohi Vinaik et al, 2022, Handbook of Stem Cell Therapy CrossRef
  5. The Secretome of Irradiated Peripheral Mononuclear Cells Attenuates Hypertrophic Skin Scarring
    Vera Vorstandlechner et al, 2023, Pharmaceutics CrossRef
  6. Current developments and opportunities of pluripotent stem cells-based therapies for salivary gland hypofunction
    Wenpeng Song et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
  7. Scar Management in the Pediatric and Adolescent Populations
    Andrew C. Krakowski et al, 2016, Pediatrics CrossRef
  8. Stem cell-based therapy for fibrotic diseases: mechanisms and pathways
    Marjan Taherian et al, 2024, Stem Cell Research & Therapy CrossRef
  9. Emerging Technologies in Scar Management: The Role of Allogeneic Cells
    Clarisse Ganier et al, 2020, Textbook on Scar Management CrossRef
  10. Stem Cells in Wound Healing and Scarring
    Roohi Vinaik et al, 2022, Handbook of Stem Cell Therapy CrossRef
  11. Gene expression profile in human induced pluripotent stem cells: Chondrogenic differentiation in vitro, part A
    Wiktoria Maria Suchorska et al, 2017, Molecular Medicine Reports CrossRef
  12. Will stem cells bring hope to pathological skin scar treatment?
    Qiankun Li et al, 2016, Cytotherapy CrossRef
  13. Suppressive effects of human fetal keratinocytes on the proliferation, differentiation and extracellular matrix synthesis of human hypertrophic scar fibroblasts in vitro
    Zhe Wang et al, 2017, Molecular Medicine Reports CrossRef
  14. Structure‐based derivation of peptide inhibitors to target TGF‐β1 receptor for the suppression of hypertrophic scarring fibroblast activation
    Huan Hu et al, 2017, Chemical Biology & Drug Design CrossRef
  15. Human-specific gene CHRFAM7A mediates M2 macrophage polarization via the Notch pathway to ameliorate hypertrophic scar formation
    Tianya Li et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  16. A systematic review of the efficacy, safety and satisfaction of regenerative medicine treatments, including platelet‐rich plasma, stromal vascular fraction and stem cell‐conditioned medium for hypertrophic scars and keloids
    Alireza Jafarzadeh et al, 2024, International Wound Journal CrossRef
  17. Structure‐based discovery and redesign of TGF‐β1 Elbow epitope recognition by its type‐II receptor in hypertrophic scarring biotherapy
    Xiaoting Chen et al, 2021, Journal of Molecular Recognition CrossRef